Crestchem Ltd
Incorporated in 1991, Crestchem Ltd is in
the field of processing, manufacturing, and trading and marketing, of specialty chemical
ingredients,[1]
- Market Cap ₹ 41.4 Cr.
- Current Price ₹ 138
- High / Low ₹ 193 / 73.0
- Stock P/E 15.3
- Book Value ₹ 33.0
- Dividend Yield 0.73 %
- ROCE 43.4 %
- ROE 31.2 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.6%
Cons
- Promoter holding is low: 30.0%
- Debtor days have increased from 36.1 to 44.5 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.13 | 0.14 | 0.05 | 0.10 | 6.15 | 7.62 | 7.90 | 16.66 | 21.18 | 24.98 | 29.61 | |
| 0.23 | 0.18 | 0.34 | 0.29 | 0.26 | 5.59 | 6.95 | 7.15 | 15.84 | 18.40 | 21.66 | 26.43 | |
| Operating Profit | -0.14 | -0.05 | -0.20 | -0.24 | -0.16 | 0.56 | 0.67 | 0.75 | 0.82 | 2.78 | 3.32 | 3.18 |
| OPM % | -155.56% | -38.46% | -142.86% | -480.00% | -160.00% | 9.11% | 8.79% | 9.49% | 4.92% | 13.13% | 13.29% | 10.74% |
| 0.89 | 0.19 | 0.08 | 0.03 | 0.02 | 0.03 | 0.05 | 0.08 | 0.15 | 0.26 | 0.44 | 0.66 | |
| Interest | 0.02 | 0.02 | 0.04 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.05 | 0.01 |
| Depreciation | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.05 | 0.05 | 0.07 |
| Profit before tax | 0.68 | 0.12 | -0.16 | -0.22 | -0.16 | 0.57 | 0.68 | 0.78 | 0.94 | 2.98 | 3.66 | 3.76 |
| Tax % | 10.29% | 25.00% | 0.00% | -13.64% | 0.00% | 22.81% | 14.71% | 26.92% | 26.60% | 27.85% | 25.41% | 27.93% |
| 0.61 | 0.09 | -0.16 | -0.19 | -0.17 | 0.44 | 0.57 | 0.57 | 0.69 | 2.15 | 2.73 | 2.71 | |
| EPS in Rs | 2.03 | 0.30 | -0.53 | -0.63 | -0.57 | 1.47 | 1.90 | 1.90 | 2.30 | 7.17 | 9.10 | 9.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.98% | 10.99% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 72% |
| 5 Years: | 31% |
| 3 Years: | 21% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 37% |
| 3 Years: | 58% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 31% |
| 3 Years: | 14% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 39% |
| 3 Years: | 41% |
| Last Year: | 31% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves | -2.09 | -2.00 | -2.16 | -2.36 | -2.53 | -2.08 | -1.51 | -0.94 | -0.25 | 1.90 | 4.48 | 6.89 |
| 0.37 | 0.35 | 0.60 | 0.14 | 0.28 | 0.02 | 0.63 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.22 | 0.05 | 0.05 | 0.04 | 0.14 | 1.35 | 0.87 | 0.96 | 2.04 | 2.24 | 3.07 | 6.40 | |
| Total Liabilities | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 16.29 |
| 0.04 | 0.04 | 0.04 | 0.11 | 0.12 | 0.10 | 0.14 | 0.11 | 0.10 | 0.17 | 0.26 | 0.19 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| 1.46 | 1.36 | 1.45 | 0.71 | 0.77 | 2.19 | 2.85 | 3.18 | 4.69 | 6.97 | 10.29 | 16.02 | |
| Total Assets | 1.50 | 1.40 | 1.49 | 0.82 | 0.89 | 2.29 | 2.99 | 3.29 | 4.79 | 7.14 | 10.55 | 16.29 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | -0.27 | -0.04 | -0.70 | -0.02 | 0.33 | 0.39 | 0.82 | 2.21 | 0.35 | 1.55 | ||
| 0.06 | 0.34 | 0.64 | 0.12 | 0.01 | -0.35 | -0.39 | -0.83 | -1.34 | -1.07 | -0.88 | ||
| -0.05 | -0.02 | -0.04 | -0.01 | -0.01 | 0.00 | -0.02 | -0.02 | -0.01 | -0.01 | -0.09 | ||
| Net Cash Flow | 0.06 | 0.05 | 0.55 | -0.58 | -0.02 | -0.02 | -0.01 | -0.02 | 0.86 | -0.72 | 0.59 | |
| Free Cash Flow | 0.07 | -0.30 | -0.07 | -0.81 | -0.02 | 0.32 | 0.33 | 0.82 | 2.19 | 0.23 | 1.41 | |
| CFO/OP | -36% | 420% | 20% | 292% | 12% | 75% | 75% | 139% | 300% | 43% | 52% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 336.92 | 469.29 | 730.00 | 292.00 | 71.81 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 | 44.50 |
| Inventory Days | 60.83 | 0.00 | 73.00 | 0.00 | 182.50 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 60.83 | 73.00 | 365.00 | 91.06 | ||||||||
| Cash Conversion Cycle | 0.00 | 336.92 | 469.29 | 730.00 | 109.50 | -18.50 | 67.54 | 41.58 | 0.44 | 26.37 | 37.41 | 44.50 |
| Working Capital Days | -1,987.22 | -645.77 | -1,016.79 | 438.00 | -292.00 | 3.56 | 12.93 | -2.77 | -36.81 | -1.21 | 8.47 | -13.93 |
| ROCE % | -13.40% | 10.65% | -8.60% | -18.92% | -19.61% | 67.46% | 45.75% | 35.96% | 37.40% | 78.17% | 59.94% | 43.41% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count |
|
||||||||||
| Customer Concentration (Top Customer Revenue Share) % |
|||||||||||
| Concentration (Top 3 Customers Revenue Share) % |
|||||||||||
| Research and Technology Expenses INR Thousands |
|||||||||||
| Number of Reportable Business Segments Count |
|||||||||||
| Core Product Forms (Caprylic/Capric Triglycerides) Count |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure under Regulation 30A of LODR
1d - Submitted newspaper clipping for audited consolidated results year ended March 31, 2026, published May 31, 2026.
-
Corporate Action-Board to consider Dividend
1d - Board approved FY26 audited results, recommended Rs.1.50 dividend, reappointments, and Rs.2.25 crore subsidiary investment.
-
Board Meeting Outcome for Board Has Considered And Adopted Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended On 31St March,2026
29 May - Crestchem approved FY26 audited results, Rs.1.50 final dividend, reappointments, and up to Rs.2.25 crore subsidiary investment.
-
Board Meeting Intimation for Board Meeting Of The Crestchem Limited Held On 26-05-2026 Is Rescheduled On 29-05-2026 At 12.15 (Noon) Agenda Remains The Same
26 May - Board meeting adjourned to May 29, 2026 at 12:15 noon; agenda unchanged.
-
Board Meeting Intimation for To Consider And Approve Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of A Final Dividend, If Any
18 May - Board meets May 26, 2026 to approve FY26 results, consider dividend, reappointments, and Rs.2.25 crore subsidiary investment.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
CL specializes in manufacturing, processing, marketing, and exporting nutraceutical ingredients used in health food, personal care, and specialty chemicals. Its key products, Caprylic/Capric Triglycerides in oil and powder form, along with downstream derivatives, also have industrial applications.